@article{JTD30242,
author = {Monisha Sudarshan},
title = {Locoregional and oligometastatic recurrence of esophageal cancer—what are the management strategies?},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 13},
year = {2019},
keywords = {},
abstract = {Over the past few decades, prognosis of esophageal cancer has improved with the advent of multimodality treatment and refinement of surgical techniques and perioperative care. A 5% 5-year survival across all stages was quoted in the 1960s which has evolved to a 20% all stage 5-year survival today (1). Clearly the reality of esophageal cancer is still grim and there is progress to be made. Within the cohort of patients that are operable, nearly 50% of patients will recur (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/30242}
}